| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Piramal Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹148.05 |
| 52 Week High | ₹166.70 |
| 52 Week Low | ₹82.15 |
| Beta | 0 |
| 1 Month Change | 3.28% |
| 3 Month Change | 11.74% |
| 1 Year Change | 80.66% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -22.08% |
Recent News & Updates
We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings
May 21
It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)
Mar 26Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)
Feb 28Recent updates
We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings
May 21It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)
Mar 26Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)
Feb 28Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161
Feb 02Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)
Nov 09Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)
Aug 11Shareholder Returns
| PPLPHARMA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.3% | -1.8% | -1.9% |
| 1Y | 80.7% | 51.6% | 41.0% |
Return vs Industry: PPLPHARMA exceeded the Indian Pharmaceuticals industry which returned 51.6% over the past year.
Return vs Market: PPLPHARMA exceeded the Indian Market which returned 41% over the past year.
Price Volatility
| PPLPHARMA volatility | |
|---|---|
| PPLPHARMA Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: PPLPHARMA has not had significant price volatility in the past 3 months.
Volatility Over Time: PPLPHARMA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 6,295 | n/a | www.piramal.com/businesses/piramal-pharma/ |
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.
Piramal Pharma Limited Fundamentals Summary
| PPLPHARMA fundamental statistics | |
|---|---|
| Market cap | ₹196.28b |
| Earnings (TTM) | ₹178.20m |
| Revenue (TTM) | ₹81.71b |
1,101x
P/E Ratio2.4x
P/S RatioIs PPLPHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PPLPHARMA income statement (TTM) | |
|---|---|
| Revenue | ₹81.71b |
| Cost of Revenue | ₹29.54b |
| Gross Profit | ₹52.17b |
| Other Expenses | ₹51.99b |
| Earnings | ₹178.20m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 63.85% |
| Net Profit Margin | 0.22% |
| Debt/Equity Ratio | 57.6% |
How did PPLPHARMA perform over the long term?
See historical performance and comparison